A.P. Pharma Inc (OTC:APPA) Keeps Itself Liquid for Till FDA Approval

Las Vegas, NV -- (SBWIRE) -- 02/05/2013 -- A.P. Pharma, Inc. (OTC:APPA) has its fingers crossed for APF530 which is developed from the company’s proprietary Biochronomer polymer based drug delivery system. According to company’s new system a drug which is injected once or twice a day will be required to consume only once in two or three weeks.

A.P. Pharma Inc’s new systems will benefit patients miraculously related to chemotherapy related nausea. The company not only will be benefiting drug sales but also anticipates that its Biochronomer technology will be legitimized.

The company reported cash and cash equivalents of $60 million in its last quarterly balance sheet.This shows that the company has enough funds to move toward the step of product launch. The company’s total balance sheet footing accumulates up to $61.76 million which depicts that cash and current assets have the highest proportion in company’s total assets while long term assets are stood at $0.13 million.

The share price witnessed the correction of 0.65 percent in last trading session to settle at $0.770. Share was traded actively with 2.23 million shares for the day while its average volume stands at 1.38 million shares per day.

To find out what OTCMAGIC projects for A.P. Pharma Inc for both short term and long term please click here: APPA

OTCMAGIC Spends all day scouring the markets for the next huge Stock Picks. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in Hot Stocks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.